Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q1- Text added to 2020 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
acute, alfa, amplify, AstraZeneca, baseline, bone, border, called, cardiac, clarification, clear, cohort, concurrently, contractile, count, daily, deplete, diminish, diminished, discourage, dozen, ebb, ejection, Emcure, epoetin, febrile, fell, fraction, granulocyte, heart, Heritage, HFrEF, intermediate, intermittent, Italy, kit, LP, lung, mecarbil, mg, myosin, myotrope, NCCN, neutropenia, newer, omecamtiv, Onpro, onset, opened, pace, payoff, pendency, placebo, plaque, Pool, preclude, prioritize, pro, prolia®, rata, reallocation, reconsideration, reevaluate, reimpose, reinstate, reinstatement, relaxation, respiratory, resume, resumed, resurgence, rheumatology, score, Spain, sPGA, static, statistically, stemming, stopped, stricter, syndrome, therefrom, timeline, unclear
Removed:
adding, affiliated, banc, BBB, BioPharma, brought, challenge, closely, david, declined, decreased, denied, en, established, high, Hospira, impacted, institute, inter, jury, launched, manufacture, meline, moving, multidistrict, opinion, panel, periodically, petition, Pfizer, preliminary, purposed, rehearing, requesting, restructuring, scheduled, separate, sheet, Teva, unfavorable
Valuein 2020 Q1 filing- Value in 2020 Q2 filing
Original filings
Filing view